Our data revealed that, despite their low density in tumor stroma, CD34_CAFs have a significant influence on LVI, PnI, NPI, G, recurrence, and survival in some of the most aggressive BC subtypes such as HER2 and TNBC. This evidence concerns the gene ERBB2 and neoplasm.